Introduction
According to World Health Organization (WHO), stroke may be defined as sudden development of neurological deficit, focal or global, persisting for more than 24 hours or patient dies within 24 hours, which is vascular in origin and non-epileptic and nontraumatic in nature 1 . Stroke, after heart disease and cancer, is the third most common cause of death after the age of 40 2 .
Stroke is the commonest neurological disorder of adult life and about 50 percent of the neurological diseases among adult admitted patients in a general hospital, and it is also the leading cause of disability in adults 3 . Of all the stroke cases, 85 percent are due to ischaemic infarction and 15 percent are due to haemorrhage 4 .
There is no fundamental study regarding the relationship between blood lipids and ischaemic stroke among Bangladeshi population, but there are studies which show hypercholesterolaemia is a risk factor for stroke 5 .
Bangladesh is a developing country and her health budget is minimum. Strokes are causing a great burden for the family, society, community as well as the nation. So, we should think about known modifiable risk factors of stroke, proper control of which plays an important role in the primary prevention of the disease.
Materials and Methods
This study was conducted in the Department of Nurology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka from March to October, 2006. This study included 30 acute ischaemic stroke patients diagnosed by history, clinical findings and confirmed by CT/MRI scan of head within 2 weeks of attack. Both man and woman age ranging from 40-90 years were eligible to enter into the study. The same number of age and sex matched nonstroke patients who gave blood for analysis were included as control.
Age, sex, risk factors for stroke such as hypertension, hypercholesterolaemia, cigarette smoking, diabetes mellitus, history of previous stroke or TIA were evaluated in all patients, together with symptoms of stroke. Hypertension was diagnosed when the blood pressure measured in the hospital was > 160/95 mm Hg or if the patient was taking antihypertensive agents. Glucose intolerance was diagnosed if a patient was using oral hypoglycemic agents or insulin and/or if the fasting blood glucose level in the hospital exceeded 6.1 mmol/L and /or the glycosylated hemoglobin level exceeded 6.4%. Hypercholesterolemia was, diagnosed if a patient was taking lipidlowering agents and / or if the serum cholesterol level exceeded 200 mg/dl. Patients were categorized as being either nonsmokers (never smoked cigarettes or quit >3 years ago) or smokers (current smoker) or gave up cigarette smoking < 3 years ago.
All relevant informations were recorded in a predesigned questionnaire. Collected data were complied and appropriate analyses were carried out using computer based software, Statistical Package for Social Science (SPSS). P value <0.05 was taken as minimum level of significance.
Results
A total number of 30 cases and 30 controls were enrolled in the study. Table-IX showed association of triglyceride and infarction. Triglyceride was raised in maximum number of both cortical and subcortical infarct groups. Table-X showed total serum cholesterol level in case and control groups. Table- XI showed HDL-cholesterol was significantly low in 70% cases compared to 26.7% control. Table- XII showed normal LDL-cholesterol label in 50% and raised in rest 50% cases, whereas LDL-cholesterol was raised in 30% subjects of control groups. Table- XIII showed serum triglyceride levels were raised in 60% subjects of case groups and 26.7% subjects of control groups. Chi-square test * * = significant. 
Discussion
This was an observational study and carried out to see the association of dyslipidaemia in cortical versus subcortical infarct among ischaemic stroke patients.
In this study the age range was 40 to 90 years with mean (±SD) 60.93±10.70 years in cases and 57.90±12.14 years in controls.
The male--female ratio was 1:0.43 in cases and 1:0.58 in controls.
Majority of the cases were in between 60-69 years and mean age (±SD) 60.93+10.70 years. This is consistant with the study conducted by Victor and Ropper 6 .
In this study male female ratio was 1:0.43. Cull and Will 7 showed that stroke affects males 1.5 times more often than females. In this study, 66.7% stroke patients were smoker. In a study done by Hayee et al 8 .
showed 69.84% smokers among their stroke patients.
In this study 60% stroke patients were hypertensive. Alam et al. 9 in their study of 1020 stroke patients had shown 75% patients were hypertensive. Kannel and Wolfe 10 showed that 10.24% strokes were attributable to diabetes. In this study, 33.3% stroke patients were suffering from diabetes mellitus. This is consistent with study conducted by Karapanayiotides et al 11 .
In this study 50% patients had hypercholesterolaemia (both total cholesterol and LDL-cholesterol). Amarenco et al 12 . in their study of 250 stroke patients had shown that 31.2% cases had hypercholesterolaemia. The difference may be due to small sample size in this study.
In this observational study total cholesterol levels were (mean±SD) 206.16±41.21 and 184.77±30.59 mg/dl in cases and controls, respectively (P<0.05). Total serum cholesterol was raised in both cortical and subcortical infracts in 50% of cases in comparison to 33.3% of controls.
LDL-cholesterol levels were (mean±SD) 138.58 ±42.84 and 118.03±35.73 mg/dl in case and control groups, respectively (P<0.05). LDL-cholesterol was raised in both cortical and subcortical infarct in 50% of cases compared to 30% of controls.
Serum triglyceride levels (mean±SD) were 181.60±84.55 and 138.00±62.01 mg/dl in case and control groups, respectively (P<0.05). Serum triglyceride was raised in 60% of case group and 26.7% of control subjects (P<0.01).
In this study HDL-cholesterol were (mean±SD) 37.56±5.97 mg/dl in case group and 40.97±6.66 mg/dl in control group (P<0.05). HDL-cholesterol was significantly low in cases (70%) compared to control subjects (26.7%) (P<0.01). HDL-cholesterol was significantly low in cases of cortical infarct in 77.3% cases compared to 50% cases of subcortical infarct (P<0.01).
Tell et al 13 showed a relationship between blood lipids and/or lipoprotein and the extent or severity of cerebrovascular atherosclerosis in all but three of 26 reviewed studies, in some of which HDLcholesterol levels were negatively associated with carotid atherosclerosis in multivariate analysis.
Salonen et al. 14 found positive association with serum cholesterol and triglyceride level in their study of ischaemic stroke. Iso et al. 15 in their study detected higher cholesterol level in ischaemic stroke and lower value in haemorrhagic stroke. Quizibash et al. 16 in their study of TIA and minor stroke detected significantly higher total cholesterol, LDL-cholesterol and lower value for HDL-cholesterol in their age and sex -matched controls and concluded that high total serum cholesterol and LDLcholesterol, triglyceride and low HDLcholesterol are risk factors for ischaemic stroke. Boutron et al. 17 in a study of cerebral infarct (61 cases) and 31 TIA cases compared with matched control and observed maximum increase of total serum cholesterol, LDL-cholesterol and triglyceride with decrease in HDLcholesterol.
In the Framingham study, the authors first assessed the association between HDLcholesterol and stroke prospectively, an inverse relation was identified between HDLcholesterol and atherothrombotic brain infarction among men but this was weak and non-significant. In the Copenhagen City heart study, Lindenstrom et al. 18 found an inverse association between HDLcholesterol and risk of ischaemic stroke.
Both studies based the analysis on a 6-year follow-up. In the Framingham study, there were 51 atherothrombotic brain infarcts among a cohort of 2723 subjects and the Copenhagen City Heart Study included 279 non-haemorrhagic stroke cases among 11,342 subjects. This study showed that low serum HDL-cholesterol is a factor for ischaemic stroke.
Adam et al. 19 in a study established that patients with cortical subtype of cerebral infarction were shown to have lower HDLcholesterol levels than counterparts with subcortical strokes, suggesting that HDL-cholesterol may be a risk factor for cortical but not for subcortical infarction. This study also correlates with this study as it was found that serum HDL-cholesterol was significantly low (P<0.01) in cases of cortical infarct (77.3%) but not in case of subcortical infarct.
A long-term observational study indicates that low levels of HDL-cholesterol, in addition to making an increased risk of coronary heart disease mortality, also predict ischaemic stroke mortality albeit to a lesser extent. Levels of HDL-cholesterol are determined by environmental and genetic factors 20 . A direct antiatherogenic role of HDL-cholesterol has been assumed because of its various potentially antiatherogenic properties, including the ability to trigger the flux of cholesterol from peripheral cells to the liver (reverse cholesterol transport) 21 . Physical activity 22 , alcohol intake 23 , smoking cessation 24 and possibly losing weight 25 can elevate HDL-cholesterol and it has been known for a quarter of a century that drugs, such as fibric acid derivatives or niacin have the same effect.
Whether increasing HDL-cholesterol would reduce the incidence of cardiovascular disease is not yet clear. Large-scale controlled clinical trials are currently testing the efficacy of pharmacologically raising HDL -cholesterol levels among coronary heart disease patients 26 .
Conclusion
This case-control study showed significant differences of serum lipids in cases and controls in our community. They are important risk factors for ischaemic stroke. Dyslipidaemia is more associated with cortical infarct than lacunar infarct. It is a modifiable risk factor. So, by changing lifestyle, diet and taking regular physical exercise and losing weight in case of over-weight, we can reduce the risk of dyslipidaemia. We may also reduce it by taking various lipid-lowering medications if cannot be reduced by non-pharmacological measures.
Recommendations
Overall, patients need health education programme about modifiable risk factors, morbidity and mortality of stroke. Hyperlipidaemia is a modifiable risk factor, and one should be informed about its deleterious effects. This study was carried out among hospitalized patients, and sample size was small. Therefore, further community-based prospective cohort study with large sample size is required to establish dyslipidaemia as a risk factor for cortical infarct but not for subcortical infarct.
